KIM HELEN SUSAN purchased 835K shares of AKTIS ONCOLOGY, INC. on the open market
Open‑market purchase worth $15.03M. The strongest form of insider conviction signal.
Common Stock
Shares
+4.86M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+812.46K
Price / share
$18.00
Trade value
$14.62M
% of position
Common Stock
Shares
+134.84K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+22.55K
Price / share
$18.00
Trade value
$405.81K
% of position
Net shares
+5.83M
Net value
$15.03M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/12/2026 | C · Conversion | +4.86M | — | — | New position | 0.00 | 4.86M |
| Common Stock Indirect | 1/12/2026 | P · Purchase | +812.46K | $18.00 | $14.62M | 16.7% | 4.86M | 5.67M |
| Common Stock Indirect | 1/12/2026 | C · Conversion | +134.84K | — | — | New position | 0.00 | 134.84K |
| Common Stock Indirect | 1/12/2026 | P · Purchase | +22.55K | $18.00 | $405.81K | 16.7% | 134.84K | 157.39K |
| Total | +5.83M | $15.03M | ||||||
Series A Redeemable Convertible Preferred Stock
Common Stock
3.90M shares
Shares
−14.84M
Strike price
Held after
0.00
Exercisable
—
Series A Redeemable Convertible Preferred Stock
Common Stock
108.23K shares
Shares
−411.75K
Strike price
Held after
0.00
Exercisable
—
Series B Redeemable Convertible Preferred Stock
Common Stock
959.09K shares
Shares
−3.65M
Strike price
Held after
0.00
Exercisable
—
Series B Redeemable Convertible Preferred Stock
Common Stock
26.61K shares
Shares
−101.25K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Redeemable Convertible Preferred Stock Indirect | Common Stock3.90M shares | 1/12/2026 | C · Conversion | −14.84M | — | 0.00 | |
| Series A Redeemable Convertible Preferred Stock Indirect | Common Stock108.23K shares | 1/12/2026 | C · Conversion | −411.75K | — | 0.00 | |
| Series B Redeemable Convertible Preferred Stock Indirect | Common Stock959.09K shares | 1/12/2026 | C · Conversion | −3.65M | — | 0.00 | |
| Series B Redeemable Convertible Preferred Stock Indirect | Common Stock26.61K shares | 1/12/2026 | C · Conversion | −101.25K | — | 0.00 |